ENTITY
Intellia Therapeutics

Intellia Therapeutics (NTLA US)

17
Analysis
Health CareUnited States
Intellia Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the research and clinical development of gene editing therapies for patients with genetically-based diseases.
more
03 Dec 2024 08:10Issuer-paid

Biopharma Week in Review - December 2, 2024

The short holiday week saw another controversial name picked for NIH head, PSTX was acquired by RHHBY, AMGN underwhelmed with obesity data

Logo
139 Views
Share
26 Nov 2024 10:14Issuer-paid

Biopharma Week in Review - November 25, 2024

Last week, the CDC and CMS picks aligned with President- elect Donald Trump’s agenda, while the FDA choice felt like a compromise.

Logo
142 Views
Share
02 Jul 2024 05:19Issuer-paid

Biopharma Week in Review - July 1, 2024

We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A.

Logo
166 Views
Share
20 Oct 2021 20:20

Liquidity Risk Short Candidates: MSC Indus, Alphatec, Intellia Thera, PAR Tech

Liquidity Risk Short Candidates: MSC Indus, Alphatec, Intellia Thera, PAR Tech.  All show tight cash positions, some show significant cash burn and...

Share
01 Jul 2021 09:35Syndicated

Weekly Innovation Review (WIRE) #38

Headline Developments: We can now modify DNA inside of a human body (in vivo), thanks to some groundbreaking work announced this week

Share
x